116 related articles for article (PubMed ID: 11906549)
1. c-myc gene amplification detected in preinvasive intraepithelial cervical lesions.
Golijow CD; Abba MC; Mourón SA; Gómez MA; Dulout FN
Int J Gynecol Cancer; 2001; 11(6):462-5. PubMed ID: 11906549
[TBL] [Abstract][Full Text] [Related]
2. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction.
Aoyama C; Peters J; Senadheera S; Liu P; Shimada H
Diagn Mol Pathol; 1998 Dec; 7(6):324-30. PubMed ID: 10207671
[TBL] [Abstract][Full Text] [Related]
3. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
[TBL] [Abstract][Full Text] [Related]
5. c-myc Gene Copy Number Variation in Cervical Exfoliated Cells Detected on Fluorescence in situ Hybridization for Cervical Cancer Screening.
Zhao WH; Hao M; Cheng XT; Yang X; Wang ZL; Cheng KY; Liu FL; Bai YX
Gynecol Obstet Invest; 2016; 81(5):416-23. PubMed ID: 26808725
[TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
7. The c-myc activation in cervical carcinomas and HPV 16 infections.
Abba MC; Laguens RM; Dulout FN; Golijow CD
Mutat Res; 2004 Feb; 557(2):151-8. PubMed ID: 14729369
[TBL] [Abstract][Full Text] [Related]
8. [Comparison and analysis of expression of c-myc and p16 in cervical carcinoma].
Ruan YH; Wei WL; Zhang HX; Liang ZN; Liu BY; Chen Y
Ai Zheng; 2003 Jun; 22(6):602-6. PubMed ID: 12948409
[TBL] [Abstract][Full Text] [Related]
9. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
10. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
[TBL] [Abstract][Full Text] [Related]
11. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
12. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
13. Premalignant cervical lesions are characterized by dihydrofolate reductase gene amplification and c-Myc overexpression: possible biomarkers.
Guijon FB; Greulich-Bode K; Paraskevas M; Baker P; Mai S
J Low Genit Tract Dis; 2007 Oct; 11(4):265-72. PubMed ID: 17917571
[TBL] [Abstract][Full Text] [Related]
14. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.
Zheng X; Liang P; Zheng Y; Yi P; Liu Q; Han J; Huang Y; Zhou Y; Guo J; Li L
Int J Gynecol Cancer; 2013 Jun; 23(5):785-90. PubMed ID: 23669440
[TBL] [Abstract][Full Text] [Related]
16. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
Tanimoto H; Nagai N; Fujimoto H; Ohta S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):566-70. PubMed ID: 1619315
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the human telomerase gene in liquid-based preparations is associated with cervical dysplasia and carcinoma.
Fan YB; Wu X; Fu ZM; Wu GP
Int J Gynecol Pathol; 2010 Mar; 29(2):157-64. PubMed ID: 20173501
[TBL] [Abstract][Full Text] [Related]
18. c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.
Kübler K; Heinenberg S; Rudlowski C; Keyver-Paik MD; Abramian A; Merkelbach-Bruse S; Büttner R; Kuhn W; Schildhaus HU
Oncotarget; 2015 Jan; 6(2):825-35. PubMed ID: 25596731
[TBL] [Abstract][Full Text] [Related]
19. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Marangoz S; Güllü IH
Cancer; 1999 Jun; 85(12):2668-9. PubMed ID: 10375117
[No Abstract] [Full Text] [Related]
20. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
